Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
1.340
+0.040 (3.08%)
At close: May 12, 2025, 4:00 PM
1.350
+0.010 (0.75%)
After-hours: May 12, 2025, 7:28 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2020
Period Ending
Dec '24 Dec '20
Genetic Therapies
2.98M
Log In
Genetic Therapies Growth
-42.74%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2020
Period Ending
Dec '24 Dec '20
United States
2.98M
Log In
United States Growth
-42.74%
Log In